JP2003212811A - Method for producing cyclohexenone long-chain alcohol - Google Patents

Method for producing cyclohexenone long-chain alcohol

Info

Publication number
JP2003212811A
JP2003212811A JP2002012783A JP2002012783A JP2003212811A JP 2003212811 A JP2003212811 A JP 2003212811A JP 2002012783 A JP2002012783 A JP 2002012783A JP 2002012783 A JP2002012783 A JP 2002012783A JP 2003212811 A JP2003212811 A JP 2003212811A
Authority
JP
Japan
Prior art keywords
mmol
reaction
methyl
hexane
chain alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002012783A
Other languages
Japanese (ja)
Other versions
JP4035332B2 (en
Inventor
Bang Luu
リュー バン
Nouvel Patrick
ヌーベール パトリック
Torangaaru Delphine
トランガール デルフィーヌ
Masashi Yamada
昌司 山田
Yukio Oshiba
幸男 大柴
Hirohito Suzuki
啓仁 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Milk Products Co Ltd filed Critical Meiji Milk Products Co Ltd
Priority to JP2002012783A priority Critical patent/JP4035332B2/en
Publication of JP2003212811A publication Critical patent/JP2003212811A/en
Application granted granted Critical
Publication of JP4035332B2 publication Critical patent/JP4035332B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To easily produce a cyclohexenone long-chain alcohol with decreased reaction steps on an industrial scale at a low production cost. <P>SOLUTION: The cyclohexenone long-chain alcohol expressed by general formula (1) (A is a 10-18C alkylene or alkenylene; and R<SP>1</SP>, R<SP>2</SP>and R<SP>3</SP>are each independently H or methyl) is produced by reacting a 3-alkoxy-2-cyclohexen-1- one derivative expressed by formula (2) (R<SP>4</SP>is a 1-5C alkyl) with a Grignard reagent of a 10-18C ω-halogenoalcohol having hydroxy group protected by silylation and hydrolyzing the reaction product. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】 【0001】 【発明の属する技術分野】本発明は、反応工程が少なく
簡便で工業的に有利なシクロヘキセノン長鎖アルコール
の製造法に関する。 【0002】 【従来の技術】神経成長因子(NGF)は、脳内の海
馬、大脳皮質に特に多く存在し、神経細胞の分化、成長
を促進し、機能維持、生存に必須な栄養因子であって、
脳でコリン作動性ニューロンに作用する因子である。ア
ルツハイマー痴呆症は、コリン作動性ニューロンの変性
脱落が主要病変とされ、神経成長因子を脳内に投与して
アルツハイマー痴呆症の治療が試みられている。しかし
ながら、この神経成長因子は、分子量が12,000の
蛋白質であるため、血液脳関門を通過できず、アルツハ
イマー痴呆症の治療法としては現実的でない。これに対
し低分子量のシクロヘキセン長鎖アルコールは、経口投
与で脳内に移行し、血流脳関門を通過し、低濃度で優れ
た神経成長促進作用を有し、直接的に神経突起に作用し
て伸展させ、痴呆症等の脳疾患予防、治療薬として有用
であることが知られている(特表2001−51505
8)。 【0003】シクロヘキセノン長鎖アルコールは、従
来、シクロヘキサノン又はメチル置換2−シクロヘキセ
ン−1−オンに、ベンゼンスルフィン酸塩を酸の存在下
で反応させ、次いでエチレングリコールと反応しケター
ル体を合成し、更にω−ハロゲノアルカノールを反応さ
せてから、酸処理して保護基を脱離して製造する方法等
の複雑な反応工程で製造されている。例えば、3−メチ
ルシクロヘキセノンを出発物質として3−(14−ヒド
ロキシテトラデシル)−4−メチル−2−シクロヘキセ
ン−1−オンを製造する場合、7つの反応工程が必要で
あった。 【0004】 【発明が解決しようとする課題】このように、従来のシ
クロヘキセノン長鎖アルコールの製造法は、反応工程が
複雑で多く、煩雑であって、また製造コストも高く工業
的に不利であった。従って、本発明の目的は、反応工程
が少なく簡便であって、製造コストも低く工業的に有利
なシクロヘキセノン長鎖アルコールの製造法を提供する
ことにある。 【0005】 【課題を解決するための手段】本発明者は、公知物質を
出発物質とした反応工程が少なく、簡便なシクロヘキセ
ノン長鎖アルコールの製造法を鋭意探索したところ、公
知の1,3−シクロヘキサンジオンから容易に製造され
るシクロヘキセノンのエノール体を、水酸基をシリル化
保護したω−ハロゲノ長鎖アルコールを用いてグリニャ
ール反応に付すことにより、反応工程が少なく簡便で、
製造コストが低く工業的に有利にシクロヘキセノン長鎖
アルコールが得られることを見い出し本発明を完成し
た。 【0006】すなわち、本発明は、次の一般式(2) 【0007】 【化3】 【0008】(式中、R1、R2及びR3は各々独立して
水素原子又はメチル基を示し、R4は炭素数1〜5のア
ルキル基を示す)で表わされる3−アルコキシ−2−シ
クロヘキセン−1−オン誘導体に、水酸基をシリル化保
護した炭素数10〜18のω−ハロゲノアルコールのグ
リニャール試薬を反応させ、次いで加水分解することを
特徴とする一般式(1) 【0009】 【化4】 【0010】(式中、Aは炭素数10〜18のアルキレ
ン基又はアルケニレン基を示し、R1、R2及びR3は前
記と同じものを示す)で表わされるシクロヘキセノン長
鎖アルコールの製造法を提供するものである。 【0011】 【発明の実施の形態】本発明の原料である一般式(2)
で表わされる化合物(以下、化合物(2)という)にお
いて、R1、R2及びR3は各々独立して水素原子を示す
が、これらのうち少なくとも1個はメチル基であるのが
好ましい。具体的には、R1=CH3、R2=R3=Hであ
る場合、及びR1=R2=R3=CH3である場合が特に好
ましい。また、R4は炭素数1〜5のアルキル基を示す
が、エチル基が特に好ましい。 【0012】当該原料化合物(2)としては、3−エト
キシ−6−メチル−2−シクロヘキセン−1−オン、3
−エトキシ−2,6−ジメチル−2−シクロヘキセン−
1−オン、3−メトキシ−2,6,6−トリメチル−2
−シクロヘキセン−1−オン等が好ましい。 【0013】当該原料化合物(2)は、例えば安価に入
手可能な1,3−シクロヘキサンジオンをエノール化及
びメチル化することにより得られる。このエノール化及
びメチル化の順序は、いずれが先でもよいが、R1、R2
及びR3が全て水素原子の場合は、メチル化を必要とし
ない。 【0014】エノール化は、例えば、必要に応じてメチ
ル化された1,3−シクロヘキサンジオン(例えば、2
−メチル−1,3−シクロヘキサンジオン)に、酸触媒
の存在下、アルコール(R4OH)を反応させることに
より行なわれる。酸触媒としては、p−トルエンスルホ
ン酸、硫酸等が挙げられる。反応は、トルエン、キシレ
ン、メタノール、エタノール等の溶媒中で、60〜15
0℃の温度で、2〜10時間行なえばよい。 【0015】メチル化は、例えば、必要によりエノール
化された1,3−シクロヘキサンジオンに、例えばアル
キルリチウムとジイソプロピルアミンから得られるリチ
ウムジイソプロピルアミド等のリチウム化試薬を反応さ
せ、次いでヨウ化メチル等のメチル化剤を反応させるこ
とにより行なわれる。ここでリチウム化反応は、例え
ば、リチウムジイソプロピルアミンのテトラヒドロフラ
ン、ヘキサン等の溶液を、−80〜0℃(例えば、−7
8℃)に冷却し、テトラヒドロフラン、ヘキサン等に溶
解した必要によりエノール化された1,3−シクロヘキ
サンジオン(好ましくは、3−エトキシ−2−シクロヘ
キセン−1−オン)を加えて行なうのが好ましい。また
メチル化反応は、この反応混合物にヨウ化メチルを加え
てから、5〜30℃(例えば、室温)まで昇温し、5〜
12時間撹拌して行なうのが好ましい。 【0016】このようにして得られた化合物(2)に、
水酸基をシリル化保護した炭素数10〜18のω−ハロ
ゲノアルカノールのグリニャール試薬を反応させ、次い
で加水分解することによりシクロヘキセノン長鎖アルコ
ール(1)を製造する。ここで、シリル化保護した炭素
数10〜18のω−ハロゲノアルカノールとしては、例
えば、次式(3) 【0017】 【化5】 【0018】(式中、Xはハロゲン原子を、Aは炭素数
10〜18のアルキレン基又はアルケニレン基を、
5、R6及びR7は各々独立して炭素数1〜8のアルキ
ル基を示す)で表わされる化合物が挙げられる。ここで
Xとしては塩素原子、臭素原子、ヨウ素原子等が挙げら
れるが、臭素原子が好ましい。Aとしては炭素数10〜
18の直鎖又は分岐鎖のアルキレン基又はアルケニレン
基が挙げられるが、炭素数12〜16の直鎖又は分岐鎖
アルキレン基が好ましく、更に炭素数12〜16の直鎖
アルキレン基が好ましく、特にテトラデシレン基、ペン
タデシレン基が好ましい。R5、R6及びR7としては、
それぞれメチル基、エチル基、イソプロピル基、t−ブ
チル基等が挙げられる。 【0019】本発明で用いるグリニャール試薬は、常法
に従いシリル化保護したω−ハロゲノアルカノールとマ
グネシウムを反応させることにより得られる。 【0020】化合物(2)とグリニャール試薬との反応
は、通常のグリニャール反応と同様に、ジエチルエーテ
ル、テトラヒドロフラン等の無水溶媒中で、40〜80
℃で0.5〜3時間行なうのが好ましい。 【0021】続いて行なう加水分解反応は、例えば、p
−トルエンスルホン酸、塩酸、硫酸等の酸の存在下に行
なうのが好ましい。この加水分解反応により、R4基、
グリニャール試薬及びシリル化保護基の三者が脱離す
る。 【0022】本発明の各反応において、中間体は単離し
てから次の反応に付してもよいが、単離することなく次
の反応に付してもよい。また、本発明において反応混合
物から中間体又は目的物を単離するには、洗浄、抽出、
再結晶、各種クロマトグラフィー等を単独で又は組み合
せて行なうのが好ましい。 【0023】 【実施例】次に実施例を挙げて本発明を更に詳細に説明
する。 実施例1 3−(15−ヒドロキシペンタデシル)−
2,4,4−トリメチル−2−シクロヘキセン−1−オ
ンの合成 【0024】(1) 3−エトキシ−2−メチル−2−
シクロヘキセン−1−オンの合成 2−メチル−1,3−シクロヘキサンジオン3g(2
3.8mmol)をエタノール30mLとトルエン56mLとの
混合液に溶解し、パラトルエンスルホン酸92mg(0.
47mmol)を加えた。混合液を 時間加熱還流して反
応させた後、水/エタノール/トルエン共沸物(沸点:
78℃)を留去し、次いで残ったトルエンを減圧下で留
去した。粗生成物をシリカゲルカラムフラッシュクロマ
トグラフィー(エチルエーテル/ヘキサン:8/2)で
精製し、3−エトキシ−2−メチル−2−シクロヘキセ
ン−1−オン2.7g(17.4mmol)を得た。 【0025】収率 73% Rf(エチルエーテル/ヘキサン:80/20)=0.
371 H-NMR(200MHz,CDCl3)δ:1.32(t,3J=7.00Hz,3H,H-9),
1.67(t,4J=1.49Hz,3H,H-7), 1.94(qn,3J=6.33Hz,2H,H-
5), 2.31(t,3J=6.62Hz,2H,H-6), 2.51(td,3J=6.12Hz,4J
=1.44Hz,2H,H-4), 4.03(q,3J=7.00Hz,2H,H-8).13 C-NMR(50MHz,CDCl3)δ:7.4(C-7), 15.4(C-9), 21.1
(C-5), 25.4(C-4), 36.4(C-6), 63.5(C-8), 115.1(C-
2), 171.4(C-3), 198.9(C-1). 【0026】(2) 3−エトキシ−2,6−ジメチル
−2−シクロヘキセン−1−オンの合成 テトラヒドロフラン8mLに溶解したジイソプロピルアミ
ン2.35mL(19.45mmol)を−78℃に冷却し、
n−ブチルリチウム12.96mL(19.45mmol)を
加えた後、0℃まで昇温した。0℃で2時間撹拌後、反
応液を−78℃に冷却し、テトラヒドロフラン5mLに溶
解した3−エトキシ−2−メチル−2−シクロヘキセン
−1−オン2g(12.96mmol)を加え、1時間後に
ヨウ化メチル1.21mL(19.45mmol)を加えた
後、室温まで昇温した。反応液を一夜撹拌し、次いで水
100mLで希釈した後、エチルエーテルで3回抽出し
た。有機層を集め、塩化ナトリウム水溶液で洗浄し、硫
酸マグネシウムで乾燥し、濾過し、減圧下で濃縮した。
粗生成物は、シリカに吸収し、シリカゲルカラムクロマ
トグラフィー(エチルエーテル/ヘキサン:4/6)で
精製し、3−エトキシ−2,6−ジメチル−2−シクロ
ヘキセン−1−オン1.72g(10.24mmol)を得
た。 【0027】収率 79% Rf(エチルエーテル/ヘキサン:40/60)=0.
1 H-NMR(200MHz,CDCl3)δ:1.12(d,3H,H-8), 1.33(t,3J=
7.00Hz,3H,H-10), 1.54-1.74(m,4H,H-5,H-7), 1.98-2.1
1(m,1H,H-5'), 2.19-2.31(m,1H,H-6), 2.51-2.60(m,2H,
H-4), 4.04(qd,J=4.68Hz,J=2.33Hz,2H,H-9).13 C-NMR(50MHz,CDCl3)δ:7.4(C-7), 15.3 and 15.7(C-
8,C-10), 24.5(C-5),28.9(C-4), 39.5(C-6), 63.3(C-
9), 114.3(C-2), 170.2(C-3), 201.2(C-1). 【0028】(3) 3−エトキシ−2,6,6−トリ
メチル−2−シクロヘキセン−1−オンの合成 テトラヒドロフラン3mLに溶解したジイソプロピルアミ
ン1.45mL(10.34mmol)を−78℃に冷却し、
n−ブチルリチウム8.7mL(10.46mmol)を加え
た後、0℃まで昇温した。0℃で2時間撹拌後、反応液
を−78℃に冷却し、テトラヒドロフラン6mLに溶解し
た3−エトキシ−2,6−ジメチル−2−シクロヘキセ
ン−1−オン1.47g(8.72mmol)を加え、1時
間後にヨウ化メチル1.59mL(10.46mmol)を加
えた後、室温まで昇温した。反応液を一夜撹拌し、次い
で水100mLで希釈した後、エチルエーテルで3回抽出
した。有機層を集め、塩化ナトリウム水溶液で洗浄し、
硫酸マグネシウムで乾燥し、濾過し、減圧下で濃縮し
た。粗生成物は、シリカゲルカラムクロマトグラフィー
(エチル−エーテル/ヘキサン:4/6)で精製し、3
−エトキシ−2,6,6−トリメチル−2−シクロヘキ
セン−1−オン1.46g(8.04mmol)を得た。 【0029】収率 92.2% Rf(エチルエーテル/ヘキサン:40/60)=0.
311 H-NMR(200MHz,CDCl3)δ:1.03(s,6H,H-8,H-9), 1.30
(t,3J=7.01Hz,3H,H-11),1.64(t,4J=1.6Hz,3H,H-7), 1.7
5(t,3J=6.27Hz,2H,H-5), 2.51(tq,3J=6.29Hz,4J=1.56H
z,2H,H-4), 4.01(q,3J=6.97Hz,2H,H-10).13 C-NMR(50MHz,CDCl3)δ:8.0(C-7), 15.4(C-11), 22.6
(C-4), 24.7(C-8,C-9), 34.7(C-5), 39.5(C-6), 63.2(C
-10), 113.1(C-2), 169.0(C-3), 203.6(C-1). 【0030】(4) 15−ブロモ−1−(t−ブチル
ジメチルシロキシ)ペンタデカンの合成 (イ) 1,15−ペンタデカンジオールの合成 テトラヒドロフラン150mLに溶解したペンタデカノリ
ド5g(20.8mmol)を0℃に冷却した後、水素化ア
ルミニウムリチウム1.2g(31.2mmol)を徐々に
加えた後、室温まで昇温した。反応液を室温で3日間撹
拌後、0℃で酒石酸飽和水溶液200mLを加え、次いで
エチルエーテルで3回抽出した。有機層を集め、塩化ナ
トリウム水溶液で洗浄し、硫酸マグネシウムで乾燥し、
濾過し、減圧下で濃縮して1,15−ペンタデカンジオ
ール5.01g(20.5mmol)を得た。 【0031】収率 98.6% Rf(ヘキサン/酢酸エチル:10/90)=0.44 融点 84〜85℃1 H-NMR(200MHz,CDCl3)δ:1.28(s large,22H,H-3 to H-
13), 1.56(qn,3J=6.6Hz,4H,H-2,14), 3.64(t,3J=6.6Hz,
4H,H-1,15).13 C-NMR(50MHz,CDCl3)δ:26.5(C-3,13), 29.9(C-4 to
C-12), 33.7(C-2,C-14), 62.1(C-1,15). 【0032】(ロ) 15−ブロモ−ペンタデカン−1
−オールの合成 48%臭化水素50mLを徐々に1,15−ペンタデカン
ジオール5.08g(20.8mmol)とシクロヘキサン
50mLとの混合物に加え、加熱して6時間還流後、2層
に分離し、水層をヘキサンで3回抽出した。有機層を集
め、飽和炭酸水素ナトリウム水溶液及び塩化ナトリウム
水溶液で洗浄し、硫酸マグネシウムで乾燥し、減圧下で
濃縮した。粗生成物は、シリカに吸収させシリカゲルカ
ラムクロマトグラフィー(ヘキサン/酢酸エチル:7/
3)で精製し、15−ブロモ−ペンタデカン−1−オー
ル4.33g(14.08mmol)を得た。 【0033】収率 68% Rf(ヘキサン/酢酸エチル:60/40)=0.47 融点 61〜63℃1 H-NMR(200MHz,CDCl3)δ:1.28(s large,22H,H-3 to H-
13), 1.57(qn,3J=6.7Hz,2H,H-2), 1.86(qn,3J=6.8Hz,2
H,H-14), 3.41(t,3J=6.8Hz,2H,H-15), 3.65(t,3J=6.6H
z,2H,H-1).13 C-NMR(50MHz,CDCl3)δ:25.5(C-3), 28.1(C-13), 28.
5(C-12), 29.4(C-4 toC-11), 32.7(C-2,C-15), 33.8(C-
14), 62.9(C-1). 【0034】(ハ) 15−ブロモ−1−(t−ブチル
ジメチルシロキシ)−ペンタデカンの合成 塩化メチレン23mLに溶解した15−ブロモ−ペンタデ
カン−1−オール2.3g(7.49mmol)を、トリメ
チルアミン2.1mL(14.98mmol)、t−ブチルジ
メチルシリルクロライド2.03g(13.48mmol)
及びジメチルアミノピリジン457.6mg(3.74mm
ol)と混合し、室温で1時間撹拌した。次いで、反応液
に飽和塩化アンモニウム水溶液を加えて塩化メチレン層
(200mL)と水層(200mL)に分離した。有機層を
硫酸マグネシウムで乾燥し、濾過し、減圧下で濃縮し
た。粗生成物は、シリカゲルカラムフラッシュクロマト
グラフィー(ヘキサン/酢酸エチル:99/1)で精製
し、15−ブロモ−1−(t−ブチルジメチルシロキ
シ)−ペンタデカン2.98g(7.07mmol)を得
た。 【0035】収率 94.4% Rf(ヘキサン:100)=0.431 H-NMR(200MHz,CDCl3)δ:0.00(s,6H,Me), 0.85(s,9H,t
Bu), 1.21(s large,22H,H-3 to H-13), 1.33-1.46(m,2
H,H-2), 1.74-1.88(m,2H,H-14), 3.36(t,3J=6.89Hz,2H,
H-15), 3.55(t,3J=6.52Hz,2H,H-1).13 C-NMR(50MHz,CDCl3)δ:-5.2(Me), 26(tBu), 28.2-2
9.7(C-3 to C-13), 33(C-15), 35(C-2,C-14), 63(C-1). 【0036】(5) 3−(15−ヒドロキシペンタデ
シル)−2,4,4−トリメチル−2−シクロヘキセン
−1−オンの合成 無水エチルエーテル3mLに溶解した15−ブロモ−1−
(t−ブチルジメチルシロキシ)−ペンタデカン1g
(2.36mmol)とマグネシウム0.115gを混合
し、還流を40分間行なった後、テトラヒドロフラン2
mLに溶解した3−エトキシ−2,6,6−トリメチル−
2−シクロヘキセン−1−オン287.5mg(1.57
mmol)を加えた。4時間撹拌後、10%塩酸3mLを加
え、更に17時間撹拌し反応させた。反応液を炭酸水素
ナトリウムで中和し、エチルエーテルで3回抽出した。
有機層を集め、塩化ナトリウム水溶液で洗浄し、硫酸マ
グネシウムで乾燥し、濾過後、減圧下で濃縮した。粗生
成物は、シリカゲルカラムクロマトグラフィー(ヘキサ
ン/酢酸エチル:9/1〜6/4、濃度勾配5%)で精
製し、3−(15−ヒドロキシペンタデシル)−2,
4,4−トリメチル−2−シクロヘキセン−1−オン2
22.7mg(0.61mmol)を得た。 【0037】収率 39% Rf(ヘキサン/酢酸エチル:70/30)=0.26 融点 29〜30℃1 H-NMR(200MHz,CDCl3)δ:1.06(s,6H,H-22,23), 1.17
(m,24H,H-8 a H-19), 1.47(m,2H,H-20), 1.68(s,3H,H-2
4), 1.72(t,J=7.14Hz,2H,H-5), 2.07(m,2H,H-7),2.33
(t,J=6.9Hz,2H,H-6), 3.55(t,J=6.64Hz,2H,H-21).13 C-NMR(50MHz,CDCl3)δ:11.4(C-24), 25.8(C-19), 2
6.8(C-22,23), 28.8(C-8), 29.2-29.6(C-10 a C-18), 3
0.5(C-7), 30.9(C-9), 32.7(C-20), 34.2(C-5),36.2(C-
4), 37.4(C-6), 62.8(C-21), 130.5(C-2), 165.6(C-3),
199.1(C-1). 【0038】実施例2 3−(14−ヒドロキシテトラ
デシル)−4−メチル−2−シクロヘキセン−1−オン
の合成 【0039】(1) 3−エトキシ−6−メチル−2−
シクロヘキセン−1−オンの合成 テトラヒドロフラン50mLに溶解したジイソプロピルア
ミン3.4mL(24.4mmol)を−78℃に冷却し、n
−ブチルリチウム8.2mL(12.3mmol)を加えた
後、0℃まで昇温した。0℃で2時間撹拌後、反応液を
−78℃に冷却し、テトラヒドロフラン3mLに溶解した
3−エトキシ−2−シクロヘキセン−1−オン1.54
g(11mmol)を加え、2時間反応を続けた後、ヨウ化
メチル0.77mL(12.4mmol)を加えた後、室温ま
で昇温した。室温で18時間撹拌後、水100mLを加
え、次いでエチルエーテル100mLで3回抽出した。有
機層を集め、塩化ナトリウム水溶液で洗浄し、硫酸マグ
ネシウムで乾燥し、濾過し、減圧下で溶媒を留去し濃縮
した。粗生成物は、フラッシュクロマトグラフィー(エ
チルエーテル/ヘキサン:40/60)で精製し、3−
エトキシ−6−メチル−2−シクロヘキセン−1−オン
1.19g(7.7mmol)を得た。 【0040】収率 73% Rf(エチルエーテル/ヘキサン:70/30)=0.
411 H-NMR(200MHz,CDCl3)δ:1.13(d,3J=6.87Hz,3H,H-7),
1.33(t,3J=7.01Hz,3H,OCH2CH 3), 1.68(m,1H,H-5), 2.03
(m,1H,H-5'), 2.26(m,1H,H-6), 2.39(m,2H,H-4), 3.85
(q,3J=7.04Hz,2H,OCH 2CH3), 5.28(s,1H,H-2).13 C-NMR(50MHz,CDCl3)δ:15.03(C-7), 16.28(OCH2 C
H3), 29.33(C-4), 30.18(C-5), 41.03(C-6), 65.06(OCH
2CH3), 102.92(C-2), 177.75(C-3), 202.86(C-1). 【0041】(2) 3−(14−ヒドロキシテトラデ
シル)−4−メチル−2−シクロヘキセン−1−オンの
合成 無水エチルエーテル4mLに溶解した14−ブロモ−1−
(t−ブチルジメチルシロキシ)−テトラデカン1.8
14g(4.45mmol)とマグネシウム0.216g
(8.9mmol)を混合し、二臭化エタンを滴下し、グリ
ニャール反応を開始し、30分間反応させた。テトラヒ
ドロフラン4mLに溶解した3−エトキシ−6−メチル−
2−シクロヘキセン−1−オン0.825g(5.32
mmol)を加えた。室温て24時間撹拌後、10%塩酸1
0mLを加え、更に24時間撹拌し反応させた。反応液を
飽和炭酸水素ナトリウム水溶液10mLで中和し、エチル
エーテル15mLで3回抽出した。有機層を集め、塩化ナ
トリウム水溶液で洗浄し、硫酸マグネシウムで乾燥し、
濾過後、減圧下で濃縮した。粗生成物は、フラッシュク
ロマトグラフィー(エチルエーテル/ヘキサン:70/
30)で精製し、3−(14−ヒドロキシテトラデシ
ル)−4−メチル−2−シクロヘキセン−1−オン0.
768g(2.74mmol)を得た。 【0042】収率 55% Rf(エチルエーテル/ヘキサン:70/30)=0.
30 融点 37〜38℃1 H-NMR(200MHz,CDCl3)δ:1.18(d,3J=7.13Hz,3H,H-21),
1.25-1.59(m,24H,H-8to H-19), 1.69-1.84(m,1H,H-5),
2.01-2.57(m,6H,H-5'/H-7/H-6/H-7'/H-4/H-6'), 3.63
(t,3J=6.50Hz,2H,H-20), 5.80(s,1H,H-2).13 C-NMR(50MHz,CDCl3)δ:17.82(C-21), 25.76(C-5), 2
7.20-32.82(C-8 to C-19), 33.07(C-4), 34.23(C-7), 3
5.67(C-6), 63.07(C-20), 124.92(C-2), 170.72(C-3),
199.82(C-1). 【0043】 【発明の効果】本発明のシクロヘキセノン長鎖アルコー
ルの製造法は、反応工程が少なく簡便で、製造コストが
低く、工業的に有利である。
DETAILED DESCRIPTION OF THE INVENTION [0001] TECHNICAL FIELD The present invention relates to a method for reducing the number of reaction steps.
Simple and industrially advantageous cyclohexenone long-chain alcohol
A method for producing the same. [0002] BACKGROUND OF THE INVENTION Nerve growth factor (NGF)
Especially abundant in horses and cerebral cortex, differentiation and growth of nerve cells
Is a trophic factor essential for promoting function maintenance and survival,
It is a factor that acts on cholinergic neurons in the brain. A
Ruzheimer's dementia is a degeneration of cholinergic neurons
Shedding is the major lesion, and nerve growth factor is administered into the brain
Attempts have been made to treat Alzheimer's dementia. However
However, this nerve growth factor has a molecular weight of 12,000.
Because it is a protein, it cannot cross the blood-brain barrier,
It is not practical as a treatment for immersion dementia. Against this
Low-molecular-weight cyclohexene long-chain alcohols are orally administered.
Transfer into the brain, pass through the blood-brain barrier, and excel at low concentrations
Has a nervous growth promoting effect and acts directly on neurites.
Useful as a preventive and therapeutic drug for brain diseases such as dementia
(Table 2001-51505).
8). [0003] Cyclohexenone long-chain alcohols are
Cyclohexanone or methyl-substituted 2-cyclohexene
Benzene-1-sulfonate in the presence of an acid
And then react with ethylene glycol
And then react with ω-halogenoalkanol.
And then acid treatment to remove the protecting group
It is manufactured in a complicated reaction process. For example, 3-meth
Starting with 3-cyclohexenone as a starting material,
Roxytetradecyl) -4-methyl-2-cyclohexe
When producing 1-one, seven reaction steps are required.
there were. [0004] As described above, the conventional system
The method for producing clohexenone long-chain alcohols involves a reaction step.
Complex, many, cumbersome and expensive to manufacture
Was disadvantageous. Therefore, an object of the present invention is to provide a reaction step
Low cost and simple, low production cost and industrial advantage
To provide a process for the production of a novel cyclohexenone long-chain alcohol
It is in. [0005] Means for Solving the Problems The present inventors have prepared a known substance.
Simple cyclohexene with few reaction steps as starting materials
After a diligent search for a method for producing non-long-chain alcohols,
Easily produced from the well-known 1,3-cyclohexanedione
Of the enol form of cyclohexenone
Grignard using protected ω-halogeno long chain alcohol
The reaction is simple and requires few reaction steps.
Low production cost and industrially advantageous long chain of cyclohexenone
Found that alcohol could be obtained and completed the present invention
Was. That is, the present invention provides the following general formula (2) [0007] Embedded image (Where R1, RTwoAnd RThreeAre each independently
R represents a hydrogen atom or a methyl group;FourRepresents a group having 1 to 5 carbon atoms.
A alkoxy group)
A hydroxyl group is added to the clohexen-1-one derivative by silylation.
Of a protected ω-halogeno alcohol having 10 to 18 carbon atoms
Reacting the lignard reagent and then hydrolyzing
General formula (1) [0009] Embedded image Wherein A is an alkylene having 10 to 18 carbon atoms
R 1 represents an alkyl group or an alkenylene group;1, RTwoAnd RThreeIs before
Cyclohexenone length)
The present invention provides a method for producing a chain alcohol. [0011] BEST MODE FOR CARRYING OUT THE INVENTION The raw material of the present invention is represented by the general formula (2)
(Hereinafter referred to as compound (2))
And R1, RTwoAnd RThreeEach independently represents a hydrogen atom
But at least one of these is a methyl group
preferable. Specifically, R1= CHThree, RTwo= RThree= H
And R1= RTwo= RThree= CHThreeIs especially good
Good. Also, RFourRepresents an alkyl group having 1 to 5 carbon atoms
However, an ethyl group is particularly preferred. As the starting compound (2), 3-ethoxy
Xy-6-methyl-2-cyclohexen-1-one, 3
-Ethoxy-2,6-dimethyl-2-cyclohexene-
1-one, 3-methoxy-2,6,6-trimethyl-2
-Cyclohexen-1-one and the like are preferred. The starting compound (2) can be supplied at a low cost, for example.
Enolization of available 1,3-cyclohexanedione
And methylation. This enolization and
And methylation may be in any order.1, RTwo
And RThreeIf all are hydrogen atoms, methylation is required
Absent. The enolization is carried out, for example, by
1,3-cyclohexanedione (e.g., 2
-Methyl-1,3-cyclohexanedione), acid catalyst
In the presence of an alcohol (RFourOH)
It is done by. As the acid catalyst, p-toluenesulfo
Acid, sulfuric acid and the like. The reaction is performed in toluene and xylene
60-15 in a solvent such as methanol, methanol, ethanol, etc.
It may be performed at a temperature of 0 ° C. for 2 to 10 hours. Methylation can be carried out, for example, by
1,3-cyclohexanedione, for example,
Lithium obtained from kill lithium and diisopropylamine
Reaction with a lithiating reagent such as
And then react with a methylating agent such as methyl iodide.
Is performed by Here, for example, the lithiation reaction
For example, tetrahydrofuran of lithium diisopropylamine
Solution such as hexane and hexane at -80 to 0 ° C (for example, -7
8 ° C) and dissolved in tetrahydrofuran, hexane, etc.
1,3-cyclohex enolized as required
Sandione (preferably, 3-ethoxy-2-cyclohexyl)
(Xen-1-one). Also
In the methylation reaction, methyl iodide is added to the reaction mixture.
And then raise the temperature to 5-30 ° C (eg, room temperature)
It is preferable to carry out stirring for 12 hours. The compound (2) thus obtained is
Ω-halo having 10 to 18 carbon atoms in which a hydroxyl group is protected by silylation
React the genoalkanol Grignard reagent, then
Cyclohexenone long-chain alcohol by hydrolysis with
(1) is manufactured. Where the silylated carbon
Examples of ω-halogenoalkanols of Formulas 10 to 18 include
For example, the following equation (3) [0017] Embedded image (Where X is a halogen atom, A is the number of carbon atoms
10 to 18 alkylene groups or alkenylene groups,
RFive, R6And R7Are each independently an alkyl having 1 to 8 carbon atoms
A compound represented by the following formula: here
X includes a chlorine atom, a bromine atom, an iodine atom and the like.
However, a bromine atom is preferred. A has 10 to 10 carbon atoms
18 linear or branched alkylene groups or alkenylene
A straight-chain or branched chain having 12 to 16 carbon atoms
An alkylene group is preferable, and a straight chain having 12 to 16 carbon atoms.
Alkylene groups are preferred, especially tetradecylene groups, pens
Tadecylene groups are preferred. RFive, R6And R7as,
Each of methyl, ethyl, isopropyl, t-butyl
And a tyl group. The Grignard reagent used in the present invention can be prepared by a conventional method.
Ω-halogenoalkanol and silylation-protected
It is obtained by reacting gnesium. Reaction of compound (2) with Grignard reagent
Is the same as the usual Grignard reaction,
In an anhydrous solvent such as toluene or tetrahydrofuran.
It is preferably carried out at a temperature of 0.5 to 3 hours. The subsequent hydrolysis reaction is, for example, p
-Run in the presence of acids such as toluenesulfonic acid, hydrochloric acid, sulfuric acid, etc.
It is preferred that By this hydrolysis reaction, RFourGroup,
Grignard reagent and silylation protecting group are eliminated
You. In each reaction of the present invention, the intermediate is isolated
May be subjected to the next reaction, but without isolation
May be applied. In the present invention, the reaction mixture
Washing, extraction,
Recrystallization, various chromatography, etc., alone or in combination
It is preferable to perform it. [0023] The present invention will be described in more detail with reference to the following examples.
I do. Example 1 3- (15-hydroxypentadecyl)-
2,4,4-trimethyl-2-cyclohexene-1-o
Synthesis (1) 3-ethoxy-2-methyl-2-
Synthesis of cyclohexen-1-one 3 g of 2-methyl-1,3-cyclohexanedione (2 g
3.8 mmol) of 30 mL of ethanol and 56 mL of toluene
Dissolved in the mixture, and 92 mg of paratoluenesulfonic acid (0.
47 mmol) was added. Heat the mixture to reflux for
Water / ethanol / toluene azeotrope (boiling point:
78 ° C.), and the remaining toluene is distilled off under reduced pressure.
I left. Silica gel column flash chromatography
By chromatography (ethyl ether / hexane: 8/2)
Purified, 3-ethoxy-2-methyl-2-cyclohexe
2.7 g (17.4 mmol) of 1-one were obtained. Yield 73% Rf(Ethyl ether / hexane: 80/20) = 0.
371 H-NMR (200MHz, CDClThree) δ: 1.32 (t,ThreeJ = 7.00Hz, 3H, H-9),
1.67 (t,FourJ = 1.49Hz, 3H, H-7), 1.94 (qn,ThreeJ = 6.33Hz, 2H, H-
5), 2.31 (t,ThreeJ = 6.62Hz, 2H, H-6), 2.51 (td,ThreeJ = 6.12Hz,FourJ
= 1.44Hz, 2H, H-4), 4.03 (q,ThreeJ = 7.00Hz, 2H, H-8).13 C-NMR (50 MHz, CDClThree) δ: 7.4 (C-7), 15.4 (C-9), 21.1
(C-5), 25.4 (C-4), 36.4 (C-6), 63.5 (C-8), 115.1 (C-
2), 171.4 (C-3), 198.9 (C-1). (2) 3-ethoxy-2,6-dimethyl
Synthesis of 2-cyclohexen-1-one Diisopropylamide dissolved in 8 mL of tetrahydrofuran
2.35 mL (19.45 mmol) was cooled to -78 ° C,
12.96 mL (19.45 mmol) of n-butyl lithium
After the addition, the temperature was raised to 0 ° C. After stirring at 0 ° C for 2 hours,
The reaction solution was cooled to -78 ° C and dissolved in 5 mL of tetrahydrofuran.
3-ethoxy-2-methyl-2-cyclohexene
2 g (12.96 mmol) of -1-one was added, and after 1 hour,
1.21 mL (19.45 mmol) of methyl iodide was added.
Thereafter, the temperature was raised to room temperature. The reaction was stirred overnight and then water
After diluting with 100 mL, extract three times with ethyl ether
Was. The organic layer is collected, washed with aqueous sodium chloride solution,
Dried over magnesium acid, filtered and concentrated under reduced pressure.
The crude product is absorbed on silica and
By chromatography (ethyl ether / hexane: 4/6)
Purified, 3-ethoxy-2,6-dimethyl-2-cyclo
1.72 g (10.24 mmol) of hexen-1-one were obtained.
Was. Yield 79% Rf(Ethyl ether / hexane: 40/60) = 0.
91 H-NMR (200MHz, CDClThree) δ: 1.12 (d, 3H, H-8), 1.33 (t,ThreeJ =
7.00Hz, 3H, H-10), 1.54-1.74 (m, 4H, H-5, H-7), 1.98-2.1
1 (m, 1H, H-5 '), 2.19-2.31 (m, 1H, H-6), 2.51-2.60 (m, 2H,
H-4), 4.04 (qd, J = 4.68Hz, J = 2.33Hz, 2H, H-9).13 C-NMR (50 MHz, CDClThree) δ: 7.4 (C-7), 15.3 and 15.7 (C-
8, C-10), 24.5 (C-5), 28.9 (C-4), 39.5 (C-6), 63.3 (C-
9), 114.3 (C-2), 170.2 (C-3), 201.2 (C-1). (3) 3-ethoxy-2,6,6-tri
Synthesis of methyl-2-cyclohexen-1-one Diisopropylamide dissolved in 3 mL of tetrahydrofuran
1.45 mL (10.34 mmol) was cooled to -78 ° C,
Add 8.7 mL (10.46 mmol) of n-butyllithium
After that, the temperature was raised to 0 ° C. After stirring at 0 ° C. for 2 hours, the reaction mixture
Was cooled to -78 ° C and dissolved in 6 mL of tetrahydrofuran.
3-ethoxy-2,6-dimethyl-2-cyclohexe
Add 1.47 g (8.72 mmol) of 1-one and add 1 hour
After that, 1.59 mL (10.46 mmol) of methyl iodide was added.
Then, the temperature was raised to room temperature. The reaction was stirred overnight, then
Diluted with water (100 mL) and extracted three times with ethyl ether
did. Collect the organic layer, wash with aqueous sodium chloride,
Dry over magnesium sulfate, filter, and concentrate under reduced pressure.
Was. The crude product is purified by silica gel column chromatography.
(Ethyl-ether / hexane: 4/6)
-Ethoxy-2,6,6-trimethyl-2-cyclohex
1.46 g (8.04 mmol) of sen-1-one were obtained. [0029] Yield 92.2% Rf(Ethyl ether / hexane: 40/60) = 0.
311 H-NMR (200MHz, CDClThree) δ: 1.03 (s, 6H, H-8, H-9), 1.30
(t,ThreeJ = 7.01Hz, 3H, H-11), 1.64 (t,FourJ = 1.6Hz, 3H, H-7), 1.7
5 (t,ThreeJ = 6.27Hz, 2H, H-5), 2.51 (tq,ThreeJ = 6.29Hz,FourJ = 1.56H
z, 2H, H-4), 4.01 (q,ThreeJ = 6.97Hz, 2H, H-10).13 C-NMR (50 MHz, CDClThree) δ: 8.0 (C-7), 15.4 (C-11), 22.6
(C-4), 24.7 (C-8, C-9), 34.7 (C-5), 39.5 (C-6), 63.2 (C
-10), 113.1 (C-2), 169.0 (C-3), 203.6 (C-1). (4) 15-bromo-1- (t-butyl)
Synthesis of (dimethylsiloxy) pentadecane (A) Synthesis of 1,15-pentadecanediol Pentadecanol dissolved in 150 mL of tetrahydrofuran
5 g (20.8 mmol) was cooled to 0 ° C.
Gradually add 1.2 g (31.2 mmol) of lithium lithium
After the addition, the temperature was raised to room temperature. Stir the reaction at room temperature for 3 days.
After stirring, add 200 mL of a saturated aqueous solution of tartaric acid at 0 ° C., and then
Extracted three times with ethyl ether. Collect the organic layer and add NaCl
Wash with aqueous thorium, dry over magnesium sulfate,
Filter and concentrate under reduced pressure to give 1,15-pentadecandio.
5.01 g (20.5 mmol) were obtained. 98.6% yield Rf(Hexane / ethyl acetate: 10/90) = 0.44 Melting point 84-85 ° C1 H-NMR (200MHz, CDClThree) δ: 1.28 (s large, 22H, H-3 to H-
13), 1.56 (qn,ThreeJ = 6.6Hz, 4H, H-2,14), 3.64 (t,ThreeJ = 6.6Hz,
4H, H-1,15).13 C-NMR (50 MHz, CDClThree) δ: 26.5 (C-3,13), 29.9 (C-4 to
C-12), 33.7 (C-2, C-14), 62.1 (C-1, 15). (B) 15-bromo-pentadecane-1
-Synthesis of all 50 mL of 48% hydrogen bromide is slowly added to 1,15-pentadecane
5.08 g (20.8 mmol) of diol and cyclohexane
Add to the mixture with 50 mL and heat to reflux for 6 hours, then 2 layers
And the aqueous layer was extracted three times with hexane. Collect organic layers
Aqueous saturated sodium bicarbonate solution and sodium chloride
Wash with aqueous solution, dry over magnesium sulfate, and
Concentrated. The crude product is absorbed on silica and
Ram chromatography (hexane / ethyl acetate: 7 /
Purified in 3), 15-bromo-pentadecane-1-O
4.33 g (14.08 mmol) were obtained. Yield 68% Rf(Hexane / ethyl acetate: 60/40) = 0.47 61-63 ° C1 H-NMR (200MHz, CDClThree) δ: 1.28 (s large, 22H, H-3 to H-
13), 1.57 (qn,ThreeJ = 6.7Hz, 2H, H-2), 1.86 (qn,ThreeJ = 6.8Hz, 2
H, H-14), 3.41 (t,ThreeJ = 6.8Hz, 2H, H-15), 3.65 (t,ThreeJ = 6.6H
z, 2H, H-1).13 C-NMR (50 MHz, CDClThree) δ: 25.5 (C-3), 28.1 (C-13), 28.
5 (C-12), 29.4 (C-4 toC-11), 32.7 (C-2, C-15), 33.8 (C-
14), 62.9 (C-1). (C) 15-bromo-1- (t-butyl)
Synthesis of dimethylsiloxy) -pentadecane 15-Bromo-pentade dissolved in 23 mL of methylene chloride
2.3 g (7.49 mmol) of can-1-ol were trimmed.
Tilamine 2.1 mL (14.98 mmol), t-butyldi
2.03 g (13.48 mmol) of methylsilyl chloride
And 457.6 mg (3.74 mm) of dimethylaminopyridine
ol) and stirred at room temperature for 1 hour. Then, the reaction solution
To the methylene chloride layer
(200 mL) and an aqueous layer (200 mL). Organic layer
Dry over magnesium sulfate, filter, and concentrate under reduced pressure.
Was. The crude product was purified by silica gel column flash chromatography.
Purified by chromatography (hexane / ethyl acetate: 99/1)
And 15-bromo-1- (t-butyldimethylsiloxy)
2.98 g (7.07 mmol) of b) -pentadecane
Was. Yield 94.4% Rf(Hexane: 100) = 0.431 H-NMR (200MHz, CDClThree) δ: 0.00 (s, 6H, Me), 0.85 (s, 9H, t
Bu), 1.21 (s large, 22H, H-3 to H-13), 1.33-1.46 (m, 2
H, H-2), 1.74-1.88 (m, 2H, H-14), 3.36 (t,ThreeJ = 6.89Hz, 2H,
H-15), 3.55 (t,ThreeJ = 6.52Hz, 2H, H-1).13 C-NMR (50 MHz, CDClThree) δ: -5.2 (Me), 26 (tBu), 28.2-2
9.7 (C-3 to C-13), 33 (C-15), 35 (C-2, C-14), 63 (C-1). (5) 3- (15-hydroxypentade)
Sil) -2,4,4-trimethyl-2-cyclohexene
Synthesis of -1-one 15-bromo-1- dissolved in 3 mL of anhydrous ethyl ether
(T-butyldimethylsiloxy) -pentadecane 1 g
(2.36 mmol) and 0.115 g of magnesium
After refluxing for 40 minutes, tetrahydrofuran 2
3-ethoxy-2,6,6-trimethyl- dissolved in mL
287.5 mg of 2-cyclohexen-1-one (1.57
mmol). After stirring for 4 hours, add 3 mL of 10% hydrochloric acid.
The reaction was further stirred for 17 hours. Hydrogen carbonate solution
Neutralized with sodium and extracted three times with ethyl ether.
The organic layer is collected, washed with aqueous sodium chloride solution,
The extract was dried over magnesium, filtered, and concentrated under reduced pressure. Crude
The product was purified by silica gel column chromatography (hexa
/ Ethyl acetate: 9/1 to 6/4, concentration gradient 5%)
3- (15-hydroxypentadecyl) -2,
4,4-trimethyl-2-cyclohexen-1-one 2
22.7 mg (0.61 mmol) were obtained. Yield 39% Rf(Hexane / ethyl acetate: 70/30) = 0.26 Melting point 29-30 ° C1 H-NMR (200MHz, CDClThree) δ: 1.06 (s, 6H, H-22,23), 1.17
(m, 24H, H-8 a H-19), 1.47 (m, 2H, H-20), 1.68 (s, 3H, H-2
4), 1.72 (t, J = 7.14Hz, 2H, H-5), 2.07 (m, 2H, H-7), 2.33
(t, J = 6.9Hz, 2H, H-6), 3.55 (t, J = 6.64Hz, 2H, H-21).13 C-NMR (50 MHz, CDClThree) δ: 11.4 (C-24), 25.8 (C-19), 2
6.8 (C-22,23), 28.8 (C-8), 29.2-29.6 (C-10 a C-18), 3
0.5 (C-7), 30.9 (C-9), 32.7 (C-20), 34.2 (C-5), 36.2 (C-
4), 37.4 (C-6), 62.8 (C-21), 130.5 (C-2), 165.6 (C-3),
 199.1 (C-1). Example 2 3- (14-hydroxytetra
(Decyl) -4-methyl-2-cyclohexen-1-one
Synthesis of (1) 3-ethoxy-6-methyl-2-
Synthesis of cyclohexen-1-one Diisopropyl alcohol dissolved in 50 mL of tetrahydrofuran
3.4 mL (24.4 mmol) of the min were cooled to -78 ° C and n
8.2 mL (12.3 mmol) of -butyllithium were added.
Thereafter, the temperature was raised to 0 ° C. After stirring at 0 ° C. for 2 hours, the reaction solution was
Cooled to -78 ° C and dissolved in 3 mL of tetrahydrofuran
3-ethoxy-2-cyclohexen-1-one 1.54
g (11 mmol), and the reaction was continued for 2 hours.
After addition of 0.77 mL (12.4 mmol) of methyl, the mixture was cooled to room temperature.
The temperature rose. After stirring at room temperature for 18 hours, 100 mL of water was added.
And then extracted three times with 100 mL of ethyl ether. Yes
The organic layer was collected, washed with aqueous sodium chloride solution,
Dry over nesium, filter, evaporate under reduced pressure and concentrate
did. The crude product was purified by flash chromatography (d
(Ethyl ether / hexane: 40/60).
Ethoxy-6-methyl-2-cyclohexen-1-one
1.19 g (7.7 mmol) were obtained. Yield 73% Rf(Ethyl ether / hexane: 70/30) = 0.
411 H-NMR (200MHz, CDClThree) δ: 1.13 (d,ThreeJ = 6.87Hz, 3H, H-7),
1.33 (t,ThreeJ = 7.01Hz, 3H, OCHTwoCH Three), 1.68 (m, 1H, H-5), 2.03
(m, 1H, H-5 '), 2.26 (m, 1H, H-6), 2.39 (m, 2H, H-4), 3.85
(q,ThreeJ = 7.04Hz, 2H, OCH TwoCHThree), 5.28 (s, 1H, H-2).13 C-NMR (50 MHz, CDClThree) δ: 15.03 (C-7), 16.28 (OCHTwo C
HThree), 29.33 (C-4), 30.18 (C-5), 41.03 (C-6), 65.06 (OCH
TwoCHThree), 102.92 (C-2), 177.75 (C-3), 202.86 (C-1). (2) 3- (14-hydroxytetrade)
Sil) -4-methyl-2-cyclohexen-1-one
Synthesis 14-bromo-1- dissolved in 4 mL of anhydrous ethyl ether
(T-butyldimethylsiloxy) -tetradecane 1.8
14 g (4.45 mmol) and 0.216 g of magnesium
(8.9 mmol), and ethane dibromide was added dropwise.
The Nyar reaction was started and allowed to react for 30 minutes. Tetrahi
3-ethoxy-6-methyl- dissolved in 4 mL of drofuran
0.825 g of 2-cyclohexen-1-one (5.32
mmol). After stirring at room temperature for 24 hours, 10% hydrochloric acid 1
0 mL was added, and the mixture was further stirred and reacted for 24 hours. Reaction solution
Neutralize with 10 mL of saturated aqueous sodium hydrogen carbonate
Extracted three times with 15 mL of ether. Collect the organic layer and add NaCl
Wash with aqueous thorium, dry over magnesium sulfate,
After filtration, the mixture was concentrated under reduced pressure. The crude product is
Chromatography (ethyl ether / hexane: 70 /
30) and purified by 3- (14-hydroxytetradeci).
L) -4-Methyl-2-cyclohexen-1-one
768 g (2.74 mmol) were obtained. Yield 55% Rf(Ethyl ether / hexane: 70/30) = 0.
30 37-38 ° C1 H-NMR (200MHz, CDClThree) δ: 1.18 (d,ThreeJ = 7.13Hz, 3H, H-21),
 1.25-1.59 (m, 24H, H-8to H-19), 1.69-1.84 (m, 1H, H-5),
 2.01-2.57 (m, 6H, H-5 '/ H-7 / H-6 / H-7' / H-4 / H-6 '), 3.63
(t,ThreeJ = 6.50Hz, 2H, H-20), 5.80 (s, 1H, H-2).13 C-NMR (50 MHz, CDClThree) δ: 17.82 (C-21), 25.76 (C-5), 2
7.20-32.82 (C-8 to C-19), 33.07 (C-4), 34.23 (C-7), 3
5.67 (C-6), 63.07 (C-20), 124.92 (C-2), 170.72 (C-3),
199.82 (C-1). [0043] EFFECT OF THE INVENTION The cyclohexenone long-chain alcohol of the present invention
Is simple and requires few reaction steps.
Low and industrially advantageous.

─────────────────────────────────────────────────────
【手続補正書】 【提出日】平成14年2月27日(2002.2.2
7) 【手続補正1】 【補正対象書類名】明細書 【補正対象項目名】0024 【補正方法】変更 【補正内容】 【0024】(1) 3−エトキシ−2−メチル−2−
シクロヘキセン−1−オンの合成 2−メチル−1,3−シクロヘキサンジオン3g(2
3.8mmol)をエタノール30mLとトルエン56mLとの
混合液に溶解し、パラトルエンスルホン酸92mg(0.
47mmol)を加えた。混合液を加熱還流して反応させた
後、水/エタノール/トルエン共沸物(沸点:78℃)
を留去し、次いで残ったトルエンを減圧下で留去した。
粗生成物をシリカゲルカラムフラッシュクロマトグラフ
ィー(エチルエーテル/ヘキサン:8/2)で精製し、
3−エトキシ−2−メチル−2−シクロヘキセン−1−
オン2.7g(17.4mmol)を得た。
────────────────────────────────────────────────── ───
[Procedure amendment] [Date of submission] February 27, 2002 (2002.2.2)
7) [Procedure amendment 1] [Document name to be amended] Description [Item name to be amended] 0024 [Amendment method] Change [Content of amendment] (1) 3-ethoxy-2-methyl-2-
Synthesis of cyclohexen-1-one 3 g of 2-methyl-1,3-cyclohexanedione (2 g
(3.8 mmol) was dissolved in a mixture of 30 mL of ethanol and 56 mL of toluene, and 92 mg (0.1 mL) of paratoluenesulfonic acid was dissolved.
47 mmol) was added. After the mixture is heated to reflux for reaction, a water / ethanol / toluene azeotrope (boiling point: 78 ° C.)
Was distilled off, and then the remaining toluene was distilled off under reduced pressure.
The crude product was purified by silica gel column flash chromatography (ethyl ether / hexane: 8/2),
3-ethoxy-2-methyl-2-cyclohexene-1-
2.7 g (17.4 mmol) of ON were obtained.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 パトリック ヌーベール フランス国 67C84 ストラスブール、リ ュ・ブレイズ・パスカル 5 フランス国 立科学研究所内 (72)発明者 デルフィーヌ トランガール フランス国 67C84 ストラスブール、リ ュ・ブレイズ・パスカル 5 フランス国 立科学研究所内 (72)発明者 山田 昌司 東京都江東区新砂二丁目2番10号 明治乳 業株式会社医薬事業部内 (72)発明者 大柴 幸男 神奈川県小田原市成田540 明治乳業株式 会社医薬事業部内 (72)発明者 鈴木 啓仁 東京都江東区新砂二丁目2番10号 明治乳 業株式会社医薬事業部内 Fターム(参考) 4H006 AA02 AC22 AC25 AC44 AC80 BB15 BE01    ────────────────────────────────────────────────── ─── Continuation of front page    (72) Inventor Patrick Noubert             France 67C84 Strasbourg, France             Blaze Pascal 5 France             RIKEN (72) Inventor Delphine Trangar             France 67C84 Strasbourg, France             Blaze Pascal 5 France             RIKEN (72) Inventor Shoji Yamada             Meiji Milk 2-2-1 Shinsuna, Koto-ku, Tokyo             Pharmaceutical Business Division (72) Inventor Yukio Oshiba             540 Narita, Oitawara-shi, Kanagawa Meiji Dairies Corporation             Company Pharmaceutical Division (72) Inventor Hirohito Suzuki             Meiji Milk 2-2-1 Shinsuna, Koto-ku, Tokyo             Pharmaceutical Business Division F term (reference) 4H006 AA02 AC22 AC25 AC44 AC80                       BB15 BE01

Claims (1)

【特許請求の範囲】 【請求項1】 次の一般式(2) 【化1】 (式中、R1、R2及びR3は各々独立して水素原子又は
メチル基を示し、R4は炭素数1〜5のアルキル基を示
す)で表わされる3−アルコキシ−2−シクロヘキセン
−1−オン誘導体に、水酸基をシリル化保護した炭素数
10〜18のω−ハロゲノアルコールのグリニャール試
薬を反応させ、次いで加水分解することを特徴とする一
般式(1) 【化2】 (式中、Aは炭素数10〜18のアルキレン基又はアル
ケニレン基を示し、R1、R2及びR3は前記と同じもの
を示す)で表わされるシクロヘキセノン長鎖アルコール
の製造法。
[Claim 1] The following general formula (2): (Wherein, R 1 , R 2 and R 3 each independently represent a hydrogen atom or a methyl group, and R 4 represents an alkyl group having 1 to 5 carbon atoms) 3-alkoxy-2-cyclohexene- A 1-one derivative is reacted with a Grignard reagent of an ω-halogeno alcohol having 10 to 18 carbon atoms in which a hydroxyl group is protected by silylation, and then hydrolyzed. (Wherein, A represents an alkylene group or alkenylene group having 10 to 18 carbon atoms, and R 1 , R 2 and R 3 are the same as those described above).
JP2002012783A 2002-01-22 2002-01-22 Process for producing cyclohexenone long chain alcohols Expired - Lifetime JP4035332B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002012783A JP4035332B2 (en) 2002-01-22 2002-01-22 Process for producing cyclohexenone long chain alcohols

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002012783A JP4035332B2 (en) 2002-01-22 2002-01-22 Process for producing cyclohexenone long chain alcohols

Publications (2)

Publication Number Publication Date
JP2003212811A true JP2003212811A (en) 2003-07-30
JP4035332B2 JP4035332B2 (en) 2008-01-23

Family

ID=27649895

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002012783A Expired - Lifetime JP4035332B2 (en) 2002-01-22 2002-01-22 Process for producing cyclohexenone long chain alcohols

Country Status (1)

Country Link
JP (1) JP4035332B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087630A1 (en) * 2003-03-28 2004-10-14 Meiji Dairies Corporation Process for producing cyclohexenone long-chain alcohols
JP2019504079A (en) * 2016-01-22 2019-02-14 大鵬薬品工業株式会社 Method for preparing high purity cyclohexenone long chain alcohol

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5559127A (en) * 1978-09-04 1980-05-02 Univ Australian Novel intermediate compound for producing prostanoids and its manufacture
JPS59219256A (en) * 1983-04-28 1984-12-10 インペリアル・ケミカル・インダストリ−ズ・ピ−エルシ− Phenol derivative, manufacture and estrogenic controller containing same
JP2001089404A (en) * 1999-09-22 2001-04-03 Meiji Milk Prod Co Ltd Cyclohexenol derivative and medicine comprising the same
JP2001515058A (en) * 1997-08-13 2001-09-18 明治乳業株式会社 Cyclohexenone long-chain alcohol and drug containing the same
JP2002068973A (en) * 2000-06-16 2002-03-08 Meiji Milk Prod Co Ltd Stem cell differentiation-inducing accelerator

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5559127A (en) * 1978-09-04 1980-05-02 Univ Australian Novel intermediate compound for producing prostanoids and its manufacture
JPS59219256A (en) * 1983-04-28 1984-12-10 インペリアル・ケミカル・インダストリ−ズ・ピ−エルシ− Phenol derivative, manufacture and estrogenic controller containing same
JP2001515058A (en) * 1997-08-13 2001-09-18 明治乳業株式会社 Cyclohexenone long-chain alcohol and drug containing the same
JP2001089404A (en) * 1999-09-22 2001-04-03 Meiji Milk Prod Co Ltd Cyclohexenol derivative and medicine comprising the same
JP2002068973A (en) * 2000-06-16 2002-03-08 Meiji Milk Prod Co Ltd Stem cell differentiation-inducing accelerator

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BOWLER,J. ET AL: "Novel steroidal pure antiestrogens", STEROIDS, vol. 54, no. 1, JPN6007001942, 1989, pages 71 - 99, XP023430237, ISSN: 0000909223, DOI: 10.1016/0039-128X(89)90076-7 *
GILL,M. ET AL: "Synthesis of chiral prostanoid intermediates from phenol", JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL COMMUNICATIONS, JPN6007001950, 1979, GB, pages 121 - 3, XP000955866, ISSN: 0000909221, DOI: 10.1039/c39790000121 *
LANGLOIS,Y. ET AL: "Alkylation of diene allylic tertiary amines with Grignard reagents. In situ activation with alkyl c", TETRAHEDRON LETTERS, vol. 26, no. 8, JPN6007001943, 1985, GB, pages 1009 - 12, ISSN: 0000909222 *
MORI K., MATSUDA H.: "Synthesis of sphingosine relatives. X. Synthesis of (2S, 3R, 4E)-1-O-(.beta.-D-glucopyranosyl)-N-[30", LIEBIGS ANNALEN DER CHEMIE, JPN6007001954, 1991, DE, pages 529 - 535, XP002262862, ISSN: 0000909220 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087630A1 (en) * 2003-03-28 2004-10-14 Meiji Dairies Corporation Process for producing cyclohexenone long-chain alcohols
US7235700B2 (en) 2003-03-28 2007-06-26 Meiji Dairies Corporation Process for producing cyclohexenone long-chain alcohols
JP2019504079A (en) * 2016-01-22 2019-02-14 大鵬薬品工業株式会社 Method for preparing high purity cyclohexenone long chain alcohol
US11485696B2 (en) 2016-01-22 2022-11-01 Taiho Pharmaceutical Co., Ltd. Manufacturing method for high-purity cyclohexenone long-chain alcohol

Also Published As

Publication number Publication date
JP4035332B2 (en) 2008-01-23

Similar Documents

Publication Publication Date Title
US6552213B1 (en) Stereoselective route to produce tris-O-substituted-(E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene, an intermediate in the synthesis of trans-resveratrol
JP2000515552A (en) Total synthesis of antitumor acylfulvene
DE69736945T2 (en) BIPHENYL COMPOUNDS AND ITS APPLICATION AS ESTROGENIC AGENTS
JP2003212811A (en) Method for producing cyclohexenone long-chain alcohol
Marshall et al. Stereocontrolled total synthesis of. alpha.-and. beta.-santonin
JPH01249783A (en) Novel benzoic acid derivative and production thereof
US9994508B2 (en) Versatile and functionalised intermediates for the synthesis of vitamin D and novel vitamin D derivatives
Stork et al. Synthesis and Reactions of 1-Methyl-2-vinyl-4-hydroxycyclohexene
Chen et al. Prostaglandins and congeners. 27. Synthesis of biologically active 16-halomethyl derivatives of 15-deoxy-16-hydroxyprostaglandin E2
CA2519178C (en) Process for producing cyclohexenone long-chain alcohols
Pirkle et al. Optically active nuclear magnetic resonance solvents. VIII. Resolution of 2, 2, 2-trifluoro-1-phenylethanol
Asakawa et al. Sesquiterpene lactones of Eremanthus incanus and Porella japonica. Crystal structure and stereochemistry of eregoyazidin
CA1308731C (en) Nona-1,3,5-triene derivatives; process for preparing them and their use
Hill et al. Synthesis of 2, 3, 5-trihydroxyphenylprop-1-ene and its 4-chloro-, 6-chloro-, and 4, 6-dichloro-derivatives
Kamikawa et al. Reaction of 2, 6-dimethyl-4-methoxybenzaldehyde with methylmagnesium iodide and some properties of the reaction products
JP4826863B2 (en) Method for producing 4-substituted cyclohexanone derivative
JPS61152665A (en) Hexa-substituted benzene derivative
KR810001975B1 (en) Process for preparing anti-androgen compounds
JPH0432811B2 (en)
Gluyas Synthesis of Silicon-Based Drugs and Odourants
Kotian Synthetic approaches to Tussilagone
Shachat Grignard Reagents Containing an Hindered Carbonyl Function
JPS6236018B2 (en)
Lakshminarayan Synthetic studies of diphenyl ether and anthraquinone natural products
JPS58162547A (en) Polyprenylaldehyde

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040906

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20040906

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070919

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20071023

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20071029

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101102

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4035332

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111102

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111102

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111102

Year of fee payment: 4

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111102

Year of fee payment: 4

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111102

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121102

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121102

Year of fee payment: 5

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313114

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121102

Year of fee payment: 5

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121102

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121102

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131102

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term